CLOV
Get informed when a big investor buys or sells
+ FollowOvervalued by 171.4% based on the discounted cash flow analysis.
| Market cap | $2.30 Billion |
|---|---|
| Enterprise Value | $2.13 Billion |
| Dividend Yield | $- (-) |
| Earnings per Share | $-0.17 |
| Beta | 2.42 |
| Outstanding Shares | 522,184,385 |
| P/E Ratio | -39.89 |
|---|---|
| PEG | 1.78 |
| Price to Sales | 1.21 |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | 0.96 |
| Enterprise Value to EBIT | -37.37 |
| Enterprise Value to Net Income | -38 |
| Total Debt to Enterprise | 0 |
| Debt to Equity | 0 |
No data
Market sentiment based on institutional option activity.
| Put/Call Ratio | 0.0000▼ 57.87% |
|---|---|
| Total Calls | -▼ 100.00% |
| Total Puts | -▼ 100.00% |
Holdings and activity of institutional investors.
| Ownership % | 0.02%▼ 24.63% |
|---|---|
| Total Invested | $502,474▼ 99.78% |
| Investors Holding | 6▼ 213.00% |
No data
Clover Health is a healthcare technology company with a deeply rooted mission of improving every life. Clover uses its proprietary technology platform to collect, structure, and analyze health and behavioral data to improve medical outco...